Published in Curr Neuropharmacol on December 01, 2014
Drug Therapy for Behavioral and Psychological Symptoms of Dementia. Curr Neuropharmacol (2016) 0.75
Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol (2006) 21.58
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60
Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol (2003) 6.78
The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med (2006) 4.67
The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia (2007) 4.55
Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature (2004) 3.29
Tea polyphenols for health promotion. Life Sci (2007) 2.50
Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol (2003) 2.44
Effects of caffeine on human behavior. Food Chem Toxicol (2002) 2.32
Antioxidants accelerate lung cancer progression in mice. Sci Transl Med (2014) 2.23
Caffeine can decrease insulin sensitivity in humans. Diabetes Care (2002) 2.14
Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl (2006) 2.13
Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr (2003) 2.10
A brief introduction to FOXOlogy. Oncogene (2008) 2.07
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci (2005) 1.99
Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol (2002) 1.97
Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes (2003) 1.97
Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci (2010) 1.96
Role of selected Indian plants in management of type 2 diabetes: a review. J Altern Complement Med (2004) 1.95
Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia (1997) 1.93
Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal (2007) 1.91
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci (2001) 1.90
Effects of caffeine on human health. Food Addit Contam (2003) 1.84
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res (2009) 1.82
The role of tea in human health: an update. J Am Coll Nutr (2002) 1.81
Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol (2001) 1.74
Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med (2012) 1.70
New insights on the anticancer properties of dietary polyphenols. Med Res Rev (2006) 1.69
Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr (2008) 1.68
Phenolic content and antioxidative capacity of green and white tea extracts depending on extraction conditions and the solvent used. Food Chem (2008) 1.63
Oxidative stress and glycemic regulation. Metabolism (2000) 1.62
Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal (2005) 1.58
Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia (2006) 1.58
Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod (2007) 1.55
OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins. Trends Mol Med (2008) 1.52
Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des (2010) 1.50
Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr (2006) 1.45
Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis (1998) 1.44
Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr (2006) 1.42
Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide). J Pharmacol Exp Ther (2007) 1.38
Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res (2005) 1.35
Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol (2002) 1.35
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30
HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. J Agric Food Chem (2004) 1.29
Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol (2002) 1.27
All teas are not created equal: the Chinese green tea and cardiovascular health. Int J Cardiol (2005) 1.21
Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res (2004) 1.21
Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr (2006) 1.20
Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agric Food Chem (2006) 1.20
The impact of diabetes on cognition: what can be learned from rodent models? Neurobiol Aging (2005) 1.20
Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab (2009) 1.19
Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem (2003) 1.17
Coffee and tea consumption and risk of type 2 diabetes. Diabetologia (2009) 1.17
Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med (2013) 1.16
Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr (2006) 1.13
Possible controversy over dietary polyphenols: benefits vs risks. Chem Res Toxicol (2007) 1.13
ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim Biophys Acta (1999) 1.10
Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells. Cancer Res (2004) 1.10
Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain Res Bull (2000) 1.09
Time for tea: mood, blood pressure and cognitive performance effects of caffeine and theanine administered alone and together. Psychopharmacology (Berl) (2007) 1.09
The effects of L-theanine, caffeine and their combination on cognition and mood. Biol Psychol (2007) 1.08
Bioactive components of tea: cancer, inflammation and behavior. Brain Behav Immun (2009) 1.07
Cerebral glucose metabolism in diabetes mellitus. Eur J Pharmacol (2004) 1.07
Differential sensitivity of murine astrocytes and neurons from different brain regions to injury. Exp Neurol (2001) 1.06
Protective effect of the green tea component, L-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology (2008) 1.06
Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes (2001) 1.05
Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Res Rev (2011) 1.03
Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat. J Am Coll Nutr (2009) 1.03
l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med (2009) 1.02
Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism (2006) 1.01
Evaluation of free radical-scavenging and antihemolytic activities of quince (Cydonia oblonga) leaf: a comparative study with green tea (Camellia sinensis). Food Chem Toxicol (2009) 1.01
Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice. Arch Pharm Res (2003) 1.00
Insulin as an in vivo growth factor. Exp Neurol (2004) 0.99
The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci (2001) 0.98
White and green teas (Camellia sinensis var. sinensis): variation in phenolic, methylxanthine, and antioxidant profiles. J Food Sci (2010) 0.97
Caffeine consumption attenuates neurochemical modifications in the hippocampus of streptozotocin-induced diabetic rats. J Neurochem (2009) 0.97
Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats. Neurochem Res (1998) 0.97
The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease. Int J Mol Sci (2012) 0.96
Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J Alzheimers Dis (2010) 0.95
The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism (2007) 0.95
Protective Effects of Green Tea Extract against Hepatic Tissue Injury in Streptozotocin-Induced Diabetic Rats. Evid Based Complement Alternat Med (2012) 0.94
Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr Metab (Lond) (2012) 0.93
The combination of L-theanine and caffeine improves cognitive performance and increases subjective alertness. Nutr Neurosci (2010) 0.93
Immunogold study of interendothelial junction-associated and glucose transporter proteins during postnatal maturation of the mouse blood-brain barrier. J Neurocytol (2001) 0.93
Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J Endocrinol Invest (1994) 0.93
The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim Biophys Acta (2013) 0.93
Green tea epigallocatechin-3-gallate (EGCG) promotes neural progenitor cell proliferation and sonic hedgehog pathway activation during adult hippocampal neurogenesis. Mol Nutr Food Res (2012) 0.92
Antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells. Sci Rep (2013) 0.91
Two new neuroprotective phenolic compounds from Gastrodia elata. J Asian Nat Prod Res (2013) 0.90
Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: no evidence for protective adaptation by the blood brain barrier. Metabolism (2002) 0.90
Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr (2015) 0.89
Protection against nitric oxide toxicity by tea. J Agric Food Chem (2000) 0.89
Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta (2013) 0.88
Cerebral energy metabolism during transient hyperglycemia in patients with severe brain trauma. Intensive Care Med (2003) 0.88
Daily consumption of green tea catechin delays memory regression in aged mice. Biogerontology (2006) 0.88
FOXO3 determines the accumulation of α-synuclein and controls the fate of dopaminergic neurons in the substantia nigra. Hum Mol Genet (2013) 0.88
Recent patents on Camellia sinensis: source of health promoting compounds. Recent Pat Food Nutr Agric (2009) 0.87
Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol Res (2011) 0.86